About 361 Trademarks found that are owned by H Lundbeck As

The mark consists of the stylized characters "TRINTELLIX" in blue-green and the dot over the first letter "I" represented by concentric orange circles where an upper portion of each circle is faded out, all on a white background. The wording "VORTIOXETINE" and "TABLETS" in stylized blue-green font is placed below the word "TRINTELLIX". Below the wording is a blue-green color block design forming the shape of a partial square, with a curved line sloping downward from the top left of the square to the lower right portion of the square.

The mark consists of the stylized characters "TRINTELLIX" in blue-green and the dot over the first letter "I" represented by concentric orange circles where an upper portion of each circle is faded out, all on a white background. The wording "VORTIOXETINE" and "TABLETS" in stylized blue-green font is placed below the word "TRINTELLIX". Below the wording is an orange color block design forming the shape of a partial square, with a curved line sloping downward from the top left of the square to the lower right portion of the square.

pharmaceutical preparations, namely, antidepressants

The mark consists of the outline of a chevron composed of a stylized "M" in orange above a stylized "V" in blue, to the left of the stylized wording "MYVI" in blue.

Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; Pharmaceutical preparations and substances acting on the central nervous system; Central nervous system stimulants; Pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, headaches, migraines, pain, immune and inflammatory disorders and diseases; Diagnostic preparations, substances, reagents and agents for medical purposes

Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; Pharmaceutical preparations and substances acting on the central nervous system; Central nervous system stimulants; Pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases, headaches, migraines, pain, immune and inflammatory disorders and diseases; Diagnostic preparations, substances, reagents and agents for medical purposes

Providing personal support services for patients receiving treatment of medical disorders in the nature of companionship, help with medical forms, emotional counseling, and emotional support

Vaccines; pharmaceutical preparations for treatment and prevention of central nervous system diseases and disorders; pharmaceutical preparations acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations for the treatment and prevention of dementia, Alzheimer's disease and disorder, dizziness, seizures, strokes, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety disorder, apathy disorder, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, balance disorders, movement disorders and diseases, dyskinesia, motor disorder, tremors, schizophrenia, bipolar disorder and disease, mania, Attention Deficit Hyperactivity Disorder, Post Traumatic Stress Disorder, agitated major depressive disorder, intermittent explosive disorder, autism, melancholic depression, tourette's syndrome, progressive supranuclear palsy (PSP), restless leg syndrome, akathisia, chronic fatigue syndrome, somnolence, nausea, cancer, headache, migraine, pain, alcoholism and chemical dependency; diagnostic agents, preparations and substances for medical purposes

"VORTIOXETINE"

The color(s) red is/are claimed as a feature of the mark.

[ Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and chemical dependency; diagnostic agents, reagents, preparations and substances for medical purposes ]

The color(s) blue-green and orange is/are claimed as a feature of the mark.

Color is not claimed as a feature of the mark.